"Receptor, EphB2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An eph family receptor found widely expressed in embryonic and adult tissues. High levels of EphB2 receptor are observed in growing AXONS and NERVE FIBERS. Several isoforms of the protein exist due to multiple alternative mRNA splicing.
| Descriptor ID |
D036183
|
| MeSH Number(s) |
D08.811.913.696.620.682.725.400.850.650 D12.776.543.750.630.500.500
|
| Concept/Terms |
Receptor, EphB2- Receptor, EphB2
- EphB2 Receptors
- Receptors, EphB2
- EphB2 Protein
- EphB2-Tyrosine Kinase
- EphB2 Tyrosine Kinase
- Developmentally Regulated EPH-Related Tyrosine Kinase
- Developmentally Regulated EPH Related Tyrosine Kinase
- EphB2 Receptor
|
Below are MeSH descriptors whose meaning is more general than "Receptor, EphB2".
Below are MeSH descriptors whose meaning is more specific than "Receptor, EphB2".
This graph shows the total number of publications written about "Receptor, EphB2" by people in this website by year, and whether "Receptor, EphB2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptor, EphB2" by people in Profiles.
-
Loss of ephrin B2 receptor (EPHB2) sets lipid rheostat by regulating proteins DGAT1 and ATGL inducing lipid droplet storage in prostate cancer cells. Lab Invest. 2021 07; 101(7):921-934.
-
Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior. J Thorac Oncol. 2013 Sep; 8(9):1203-11.
-
Serrated adenoma: a distinct form of non-polypoid colorectal neoplasia? Gastrointest Endosc Clin N Am. 2010 Jul; 20(3):543-63.
-
Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity. J Biol Chem. 2003 Feb 21; 278(8):6111-9.